Literature DB >> 26611143

Post-traumatic stress disorder.

Jonathan I Bisson1, Sarah Cosgrove2, Catrin Lewis2, Neil P Robert2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26611143      PMCID: PMC4663500          DOI: 10.1136/bmj.h6161

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
Individual reactions to traumatic events vary greatly and most people do not develop a mental disorder after exposure to trauma PTSD should be considered in any patient exposed to a major traumatic event Up to 3% of adults has PTSD at any one time. Lifetime prevalence rates are between 1.9% and 8.8% Psychological treatments, particularly trauma focused psychological therapies, can be effective Although the effect sizes are not as high as for psychological therapies, drug treatments can be effective Patients with complex PTSD should receive specialist multidisciplinary care

What is post-traumatic stress disorder (PTSD)?

PTSD is a mental disorder that may develop after exposure to exceptionally threatening or horrifying events. Many people show remarkable resilience and capacity to recover following exposure to trauma.1 PTSD can occur after a single traumatic event or from prolonged exposure to trauma, such as sexual abuse in childhood. Predicting who will go on to develop PTSD is a challenge.2 Examples of the many different trajectories of PTSD symptoms after exposure to trauma

Sources and selection criteria

We identified Cochrane and other relevant systematic reviews and meta-analyses, and supplemented these with additional searches and our knowledge of the subject. Wherever possible, we used evidence from recent meta-analyses of randomised trials. Patients with PTSD are at increased risk of experiencing poor physical health, including somatoform, cardiorespiratory, musculoskeletal, gastrointestinal, and immunological disorders.3 4 It is also associated with substantial psychiatric comorbidity,5 increased risk of suicide,6 and considerable economic burden.7 8 PTSD is a widely accepted diagnosis9 but some believe that the term medicalises understandable responses to catastrophic events and further disempowers those who are already disempowered.10

How common is PTSD?

About 3% of the adult population has PTSD at any one time.11 Lifetime prevalence is between 1.9%12 and 8.8%,7 but this rate doubles in populations affected by conflict13 and reaches more than 50% in survivors of rape.5

How does PTSD present?

Symptoms include persistent intrusive recollections, avoidance of stimuli related to the trauma, negative alterations in cognitions and mood, and hyperarousal (table).14 15 A diagnosis can be made in someone whose ability to function normally has been noticeably impaired for one month according to DSM-5 criteria. Delayed presentation (sometimes years later) is common,7 including where the effects are severe.16

Symptoms required for diagnosis of PTSD

DSM-5 criteria14Proposed ICD-11 criteria17
Intrusion symptoms
Recurrent, involuntary and intrusive distressing memoriesRecurrent distressing dreams (content and/or affect related) Dissociative reaction (acting or feeling as if event is recurring)Intense or prolonged psychological distress to cuesNoticeable physiological reactions to cuesVivid intrusive memories, flashbacks, or nightmares, typically accompanied by strong and overwhelming emotions such as fear or horror, and strong physical sensations
Avoidance
Avoidance or efforts to avoid distressing thoughts or feelings about or closely associated with the traumaAvoidance or efforts to avoid external reminders (people, places, conversations, activities, objects, situations)Avoidance of thoughts and memories of the event or eventsAvoidance of activities, situations, or people reminiscent of the event or events
Negative alterations in cognitions and mood
Inability to remember an important aspect (typically due to dissociative amnesia)Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (for example, “I am bad,” “No one can be trusted,” “The world is completely dangerous”)Persistent, distorted cognitions about the cause or consequences that lead to self blame or the blame of othersPersistent negative emotional state (for example, fear, horror, anger, guilt, shame)Noticeably diminished interest or participation in important activitiesFeelings of detachment or estrangement from othersPersistent inability to experience positive emotions (for example, happiness, satisfaction, love)Not applicable
Alterations in arousal and reactivity
Irritable behaviour and angry outbursts (with little or no provocation)Reckless or self destructive behaviourHypervigilanceExaggerated startle responseProblems with concentrationSleep disturbancePersistent perceptions of heightened current threat—for example, as indicated by hypervigilance or an enhanced startle reaction to stimuli such as unexpected noises
Additional criteria for complex PTSD
Not applicableSevere and pervasive problems in affect regulationPersistent beliefs about oneself as diminished, defeated, or worthless, accompanied by deep and pervasive feelings of shame, guilt, or failure related to the stressorPersistent difficulties in sustaining relationships and in feeling close to others
Symptoms required for diagnosis of PTSD

How is PTSD diagnosed?

Box 1 describes the nature of the traumatic event(s) required by DSM-5 (diagnostic and statistical manual of mental disorders, fifth edition)14 for diagnosis and the proposed criteria by ICD-11 (international classification of diseases, 11th revision).17 Some events such as bullying, divorce, death of a pet, and learning about a diagnosis of cancer in a close family member are not deemed extreme enough to precipitate PTSD. However, they can result in almost identical symptoms and raise questions about the validity of the definitions for traumatic events.18 Exposure to actual or threatened death, serious injury, or sexual violation, in one or more of the following ways: Directly experiencing the traumatic event(s) Witnessing traumatic event(s) in others Learning that the traumatic event(s) occurred to a close family member or close friend; cases of actual or threatened death must have been violent or unintentional Experiencing repeated or extreme exposure to aversive details of the traumatic event(s) (for example, first responders collecting human remains; police officers repeatedly exposed to details of child abuse); this does not apply to exposure through electronic media, television, movies, or pictures, unless this exposure is work related Exposure to an extremely threatening or horrific event or series of events DSM-5 lists the 20 symptoms required for PTSD to be diagnosed,14 separated into four groups (table). All symptoms must be associated with the traumatic event. In the proposed criteria by ICD-11,17 PTSD will be diagnosed according to six criteria (table). To reflect the heterogeneity of PTSD, ICD-11 will introduce a new complex PTSD diagnosis (table). This requires satisfaction of the criteria for PTSD plus symptoms of mood dysregulation, negative self concept, and persistent difficulty in sustaining relationships and feeling close to others. Service users may meet the diagnostic criteria in one system but not in the other owing to the differences.19

Can PTSD be prevented?

Psychological interventions

Psychological interventions have been evaluated after traumas concerning a single incident, such as a road traffic crash and physical or sexual assaults. Meta-analyses show that brief, trauma focused, cognitive behavioural interventions can reduce the severity of symptoms when the intervention is targeted at those with early symptoms.20 21 However, non-targeted interventions (including psychoeducation, psychological debriefing, individual and group counselling, cognitive behavioural therapy (CBT) based programmes, and collaborative care based approaches) are largely ineffective.22 23 24 25

Drug interventions

No robust evidence supports the use of drug interventions.26

Prevention after large scale traumatic events

Evidence to support routine intervention after traumatic events involving many people (for example, terrorist attacks and natural disasters) is lacking. However, some evidence suggests that high levels of social support are perceived as protective.27 Consensus guidelines recommend supportive, practical, and pragmatic input but avoidance of formal clinical interventions unless indicated.28 29 30

Can PTSD be treated?

Psychological therapy

Clinical guidelines recommend trauma focused psychological therapies based on evidence from systematic reviews and meta-analyses.31 32 33 Individual trauma focused CBT and eye movement desensitisation and reprocessing (EMDR) (box 2) have been found to be equally effective.34 Therapists help patients to confront their traumatic memories through written or verbal narrative, detailed recounting of the traumatic experience, and repeated exposure to trauma related situations that were being avoided or evoked fear but are now safe (for example, driving a car where the road traffic incident occurred or walking in the busy park where an assault occurred) Focuses on identifying and modifying misinterpretations that led patients to overestimate the current threat (for example, patients who think assault is almost inevitable if they leave the house) Focuses on modifying beliefs and how patients interpret their behaviour during the trauma, including problems with guilt and shame Standardised, trauma focused procedure. Involves the use of bilateral physical stimulation (eye movements, taps, or tones), hypothesised to stimulate the patient’s information processing to help integrate the targeted event as an adaptive contextualised memory Group trauma focused CBT is also effective, but fewer studies have focused on this method.35 Non-trauma focused CBT—including components such as grounding techniques to manage flashbacks (for example, focusing on the here and now by describing items in a room), relaxation training (for example, controlled breathing and progressive muscle relaxation), positive thinking and self talk (for example, repeating positive phrases such as “I can deal with this”)—has been found to be superior to waiting list control groups and has shown similar efficacy to trauma focused CBT and EMDR immediately after treatment, but this is not maintained at follow-up.34 Non-trauma focused CBT offers a valid alternative to trauma focused therapy if the latter is poorly tolerated, contraindicated, or unavailable. It is unclear whether specific therapies are more or less effective for particular subgroups or trauma types.36 37 Research on interventions for more complex presentations of PTSD is limited.38 Evidence suggests that phased approaches may be beneficial for more complex presentations of PTSD.39 Phase based approaches target problems such as affect dysregulation, dissociation, and somatic symptoms to promote adaptive coping, a sense of safety, and stabilisation before undertaking any trauma focused intervention.

Self help programmes

Guided self help interventions for depression and anxiety disorders are being used as an alternative to face to face therapy as these interventions offer enhanced access to cost effective treatment.40 Some evidence suggests that internet based guided self help therapies effectively alleviate the symptoms of traumatic stress, but randomised controlled trials (RCTs) have historically been limited to subsyndromal populations.41 42 More recent evidence supports the efficacy of guided self help for people meeting diagnostic criteria for PTSD,43 44 45 but no head to head trials have compared guided self help with trauma focused psychological therapy administered by a therapist.

Drug treatment

The National Institute for Health and Care Excellence and World Health Organization recommend drug treatment second to trauma focused therapy.33 46 The effect sizes for drug treatments compared with placebo are inferior to those reported for psychological treatments with a trauma focus over waiting list or treatment as usual controls.33 47 Effect sizes with drug treatment are similar to those observed from use of antidepressants for depression compared with placebo.48 A recent systematic review and meta-analysis found statistically significant evidence (when at least two RCTs were available) of reduction in severity of PTSD symptoms for four drugs (fluoxetine, paroxetine, sertraline, and venlafaxine) versus placebo.47 In single RCTs, amitriptyline, GR205171 (a neurokinin-1 antagonist), mirtazapine, and phenelzine have shown superiority over placebo in reducing the symptoms of PTSD. In an RCT the α 1 adrenoceptor antagonist prazosin was found to reduce nightmares in veterans with PTSD,49 and a further RCT in veterans showed reduction in overall symptom severity.50 This suggests a possible role for α 1 adrenoceptor blockers in PTSD, although further research is needed. Olanzapine, in contrast with another antipsychotic, risperidone, has been shown to accentuate the effects of antidepressants when resistance to treatment is encountered.51 52

Combination therapy

Evidence to support the use of pharmacotherapy combined with psychological therapy over either treatment method separately is insufficient.53

How should PTSD and comorbidity be managed?

PTSD is associated with depression, anxiety disorders, and drug and alcohol use disorders. Little evidence exists for the effectiveness of psychological interventions for PTSD with comorbid substance use disorders. Some evidence suggests that trauma focused CBT can be effective with concomitant interventions to stabilise drug or alcohol use, but treatment effects are not as large as for PTSD in the absence of drug or alcohol misuse.54

What is the prognosis in PTSD?

Few longitudinal follow-up studies have been done of PTSD, but for many patients PTSD is severe and enduring.5 There is, however, good evidence that patients may benefit from treatment even when the symptoms have been present for many years.34

Are there emerging options to prevent and treat PTSD?

Several experimental studies provide hope that better or alternative ways to prevent and treat PTSD are on the way. Simple visuospatial tasks such as playing a computer game shortly after a traumatic experience reduce re-experiencing.55 For established PTSD, interest in using drugs to augment psychological therapy is increasing. The results of a recent RCT of the psychedelic 3,4-methylenedioxymethylamphetamine with psychotherapy for treatment resistant PTSD have been promising.56 57 These approaches remain in their infancy, and further well designed clinical studies are required to determine if they will live up to their early promise.

How were patients involved in this clinical review?

Sarah Cosgrove is a former patient with PTSD and a representative of the public in Cardiff University’s Traumatic Stress Research Group. Sarah is a coauthor of the paper and provides an account of her experiences in the patient’s perspective box.

A patient’s perspective

I was diagnosed with PTSD in November 2013 in the aftermath of a violent assault. From the time of the attack to the case coming to court, I had support from police and victim services enabling me to face my assailant in court with courage and conviction. But in the weeks after the judicial process had concluded, I started to unravel. Naturally a glass half full sort of person, I slid into a state of great anxiety, frightened to be alone, scared to be in a group, reluctant to go out, and terrified of staying at home. I knew something was very wrong. I had gone from being confident and outgoing, to not being able to sleep, being tearful, and experiencing episodes of unparalleled low mood. My GP immediately diagnosed PTSD. Being able to put a label on what I was going through was so helpful—it meant that there was something wrong. Fortunately, I was offered the chance to participate in a trial of a guided self help programme for sufferers of PTSD. This enabled me to both confront my experience and desensitise it, and within a few months I felt stronger than I had ever been. The programme has given me a coping strategy to employ whenever I get negative thoughts or flashbacks. It may have saved my life; at the very least it got me back to the person I used to be. A traumatic event can precipitate conditions other than PTSD, such as depression, phobic anxiety, and substance use disorders PTSD is associated with comorbidity Sensitive questioning is required to elicit symptoms of PTSD as patients may avoid volunteering their traumatic experience(s) Patients with PTSD may present in primary care with physical symptoms that are difficult to explain Trauma focused psychological therapy is the treatment of choice for PTSD, although drugs and other forms of psychological treatment can help Patient choice and availability of psychological therapy will influence the treatment given When patients present with mental or physical symptoms that cannot be fully explained after a traumatic event When patients present with characteristic symptoms of PTSD—re-experiencing, avoidance, and hyperarousal When patients disclose a history of involvement in a traumatic event When patients present with mental or physical symptoms that are difficult to explain in the absence of a disclosed traumatic event Websites providing information on the assessment and treatment of PTSD: International Society for Traumatic Stress Studies (www.istss.org) US Department of Veterans Affairs, National Centre for PTSD (www.ptsd.va.gov) Websites providing information on symptoms of PTSD and treatment options: NHS Choices PTSD (www.nhs.uk/Conditions/Post-traumatic-stress-disorder/Pages/Introduction.aspx) Royal College of Psychiatrists (www.rcpsych.ac.uk/expertadvice/problemsdisorders/posttraumaticstressdisorder.aspx) International Society for Traumatic Stress Studies (www.istss.org) National Centre for Mental Health (http://ncmh.info/conditions/post-traumatic-stress-disorder-ptsd/) US Department of Veterans Affairs, National Centre for PTSD (www.ptsd.va.gov/public/pages/fslist-self-help-cope.asp)—provides information on the symptoms of PTSD, self help, and treatment options
  38 in total

Review 1.  Post-traumatic stress disorder.

Authors:  Jonathan I Bisson
Journal:  BMJ       Date:  2007-04-14

2.  Proposals for mental disorders specifically associated with stress in the International Classification of Diseases-11.

Authors:  Andreas Maercker; Chris R Brewin; Richard A Bryant; Marylene Cloitre; Geoffrey M Reed; Mark van Ommeren; Asma Humayun; Lynne M Jones; Ashraf Kagee; Augusto E Llosa; Cécile Rousseau; Daya J Somasundaram; Renato Souza; Yuriko Suzuki; Inka Weissbecker; Simon C Wessely; Michael B First; Shekhar Saxena
Journal:  Lancet       Date:  2013-04-11       Impact factor: 79.321

3.  What happened to harmonization of the PTSD diagnosis? The divergence of ICD11 and DSM5.

Authors:  J I Bisson
Journal:  Epidemiol Psychiatr Sci       Date:  2013-04-22       Impact factor: 6.892

Review 4.  Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Authors:  Stefan Leucht; Sandra Hierl; Werner Kissling; Markus Dold; John M Davis
Journal:  Br J Psychiatry       Date:  2012-02       Impact factor: 9.319

Review 5.  Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).

Authors:  Sarah E Hetrick; Rosemary Purcell; Belinda Garner; Ruth Parslow
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

6.  Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

Authors:  Murray B Stein; Neal A Kline; Jeffrey L Matloff
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

7.  A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder.

Authors:  Brett T Litz; Charles C Engel; Richard A Bryant; Anthony Papa
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

8.  A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

Authors:  Murray A Raskind; Kris Peterson; Tammy Williams; David J Hoff; Kimberly Hart; Hollie Holmes; Dallas Homas; Jeffrey Hill; Colin Daniels; Jess Calohan; Steven P Millard; Kirsten Rohde; James O'Connell; Denise Pritzl; Kevin Feiszli; Eric C Petrie; Christopher Gross; Cynthia L Mayer; Michael C Freed; Charles Engel; Elaine R Peskind
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112

9.  Cognitive behavioral therapy for the treatment of post-traumatic stress disorder: a review.

Authors:  Nilamadhab Kar
Journal:  Neuropsychiatr Dis Treat       Date:  2011-04-04       Impact factor: 2.570

10.  The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin
Journal:  J Psychopharmacol       Date:  2010-07-19       Impact factor: 4.153

View more
  48 in total

Review 1.  Sex-Specific Epigenetics: Implications for Environmental Studies of Brain and Behavior.

Authors:  Marija Kundakovic
Journal:  Curr Environ Health Rep       Date:  2017-12

2.  Defending psychiatry or defending the trivial effects of therapeutic interventions? A citation content analysis of an influential paper.

Authors:  I A Cristea; F Naudet
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-29       Impact factor: 6.892

3.  Sleep Disturbances in Australian Vietnam Veterans With and Without Posttraumatic Stress Disorder.

Authors:  Timothy Baird; Sarah McLeay; Wendy Harvey; Rebecca Theal; Dayna Law; Robyn O'Sullivan
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

4.  Detailed Polysomnography in Australian Vietnam Veterans With and Without Posttraumatic Stress Disorder.

Authors:  Timothy Baird; Rebecca Theal; Sarah Gleeson; Sarah McLeay; Robyn O'Sullivan; Sarah McLeay; Wendy Harvey; Madeline Romaniuk; Darrell Crawford; David Colquhoun; Ross McD Young; Miriam Dwyer; John Gibson; Robyn O'Sullivan; Graham Cooksley; Christopher Strakosch; Rachel Thomson; Joanne Voisey; Bruce Lawford
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

Review 5.  Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors:  Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal:  Front Mol Biosci       Date:  2019-10-18

6.  Juvenile stress facilitates safety learning in male and female high alcohol preferring mice.

Authors:  Iris Müller; Demitra D Adams; Susan Sangha; Julia A Chester
Journal:  Behav Brain Res       Date:  2020-11-06       Impact factor: 3.332

7.  The impact of psychopathology, social adversity and stress-relevant DNA methylation on prospective risk for post-traumatic stress: A machine learning approach.

Authors:  Agaz H Wani; Allison E Aiello; Grace S Kim; Fei Xue; Chantel L Martin; Andrew Ratanatharathorn; Annie Qu; Karestan Koenen; Sandro Galea; Derek E Wildman; Monica Uddin
Journal:  J Affect Disord       Date:  2020-12-24       Impact factor: 4.839

8.  Personal and Political: Post-Traumatic Stress Through the Lens of Social Identity, Power, and Politics.

Authors:  Orla T Muldoon; Robert D Lowe; Jolanda Jetten; Tegan Cruwys; S Alexander Haslam
Journal:  Polit Psychol       Date:  2020-12-13

9.  Prevalence of traumatic psychological stress reactions in children and parents following paediatric surgery: a systematic review and meta-analysis.

Authors:  David Paul Turgoose; Stephanie Kerr; Paolo De Coppi; Simon Blackburn; Simon Wilkinson; Natasha Rooney; Richard Martin; Suzanne Gray; Lee Duncan Hudson
Journal:  BMJ Paediatr Open       Date:  2021-07-16

10.  COVID-19 pandemic and lockdown stress consequences in people with and without Irritable Bowel Syndrome.

Authors:  J-M Sabate; D Deutsch; C Melchior; A Entremont; F Mion; M Bouchoucha; S Façon; J-J Raynaud; F Zerbib; P Jouët
Journal:  Ethics Med Public Health       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.